v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue (note 11) $ 2,211 $ 2,233 $ 4,832 $ 3,672
Cost of sales 593 812 1,361 1,385
Gross profit 1,618 1,421 3,471 2,287
Operating expenses        
Research and development 6,098 4,205 10,906 8,150
Selling, general and administrative 9,326 5,058 17,537 9,856
Total operating expenses 15,424 9,263 28,443 18,006
Operating loss 13,806 7,842 24,972 15,719
Other (income) expenses        
Net finance (income) expense (343) (422) (788) (884)
Net foreign exchange (gain) loss 2,168 (520) 2,130 (1,390)
Total other (income) expenses 1,825 (942) 1,342 (2,274)
Net loss before income taxes 15,631 6,900 26,314 13,445
Income tax expense 78 19 119 59
Deferred tax recovery (14)   (14)  
Total income tax expense 64 19 105 59
Net loss attributed to shareholders for the period 15,695 6,919 26,419 13,504
Item that may be reclassified to (income) loss        
Foreign currency translation adjustment (2,713) 470 (2,816) 1,439
Net loss and other comprehensive loss for the period $ 12,982 $ 7,389 $ 23,603 $ 14,943
Loss per share (note 12)        
Basic net loss per common share $ 0.52 $ 0.28 $ 0.88 $ 0.55
Diluted net loss per common share $ 0.52 $ 0.28 $ 0.88 $ 0.55
Basic weighted average common shares outstanding 30,053,142 24,440,444 30,055,047 24,373,869
Diluted weighted average common shares outstanding 30,053,142 24,440,444 30,055,047 24,373,869
Recurring - non-capital        
Revenue (note 11) $ 1,561 $ 1,460 $ 3,362 $ 2,899
Capital equipment        
Revenue (note 11) $ 650 $ 773 $ 1,470 $ 773

Source